Volatile carboxylic acid profiling in physiological fluids: direct injection into a gas chromatograph/mass spectrometer *
We present a procedure for the profiling of the volatile carboxylic acids and neutral compounds in blood or urine using the direct injection of the acidified sample into a gas chromatograph interfaced with a mass spectrometer by a jet separator. The non-volatile components remain at the head of the SP-1000 column while the volatile components move through the column. Up to sixty physiological samples can be analyzed before any degradation in mass spectrometer operating parameters is observed.
Some inborn errors of metabolism are characterized by an increase in the plasma and/or urine concentration of carboxylic acids. Metabolic disorders such as propionic acidemia [l] , methylmalonic aciduria [2, 3] , maple syrup urine disease [4] , isovaleric acidemia [4] and glutaric acidemia type II (5,651 show increased concentrations of volatile carboxylic acids in blood and/or urine. Gas chromatography/mass spectrometry (GC/MS) represents the current method of choice for the profiling of volatile carboxylic acids [7, 8] . This method requires the isolation of carboxylic acids from physiological fluids by vacuum distillation [6] , extraction [9.10] processes preclude the detection and identification of volatile neutral compounds which may bc of clinical significance [ 11 .I 31. We have recently developed a rapid procedure for the gas chromatographic profiling of volatile carboxylic acids and neutral compounds in plasma and urine [14] which used direct injection of the acidified sample into a gas ~hr~~mat~~graph with flame ionization detection. We now report the adaptation of this technique to GC/MS employing direct injection of acidified physiological fluids into a gas chromatograph interfaced to a mass spectrometer by a jet separator. The mass spectrometer facilitates peak identification and quantification by total ion ahundance (TIA) and/or selected ion monitoring (SIM).
Materials and methods

Materiuls
All carboxylic acid standards were purchased either from Sigma Chemical Co. (St. Louis, MO, USA) or from Aldrich Chemical Company (Milwaukee, WI, USA) and were used as received.
Equipment
A Hewlett Packard 5995B GC/MS (Palo Alto. CA, USA) equipped with a 10% SP-1000/l% H,PO, on lOO/ZOO Chromosorb WAW (1.83 m X 2 mm i.d.) glass GC column (Supefco, Inc., Bellefonte, PA, USA) was used for all deter~nations.
The SP-1000 column was conditioned at 19O*C with a helium flow rate of 20 mI/min.
Periodic injection of a 1% formic acid solution was repeated until a stable baseline resulted (1-2 days).
Urine To 1.00 ml of urine was added 10 ~1 of a 1.02 mg/ml trimethylacetic acid [ll] (internal standard) solution and the pH of the sample was adjusted to 1.0 by the addition of 1 mol/l HCI. A I-PI aliquot was injected on to the SP-1000 column. GC conditions:
column, 150°C isothermal; injector, 230°C; flow rate, 20 ml He/min. Mass spectrometer:
transfer line, 28O'C; ion source, 200°C: mass analyzer. 230°C. The usual analysis time was 45-55 min.
Plasma To 1 .OO ml of 1 mmol/l HCl was added 10 ~1 of a 1.02 mg/ml trimethylacetic acid solution (internal standard). A 10-1-11 aliquot was mixed with 10 ~1 of plasma and a l-p1 aliquot was injected on to the SP-1000 column. The GC/MS parameters were the same as those used for urine sampies.
The method of standard additions was used to quantify volatile carboxylic acids. Peak height ratio (anafyte peak h~~ght/inte~a~ standard peak height) was determined from the total ion abundance chromatogram or from the selected ion chromatogram, thus permitting either to be used for quantification. In the selected ion mode, the mass (m/r) of the base peak in the mass spectrum of each acid was the ion used for quantification.
The day-to-day and run-to-Ron peak height variation was determined without an internal standard using both total ion abundance and setected ion monitoring. The GC/MS parameters were kept constant during these determinations. Figure 1 shows the total ion abundance chromatogram of a standard solution that is used to determine when a new SP-1000 column is fully conditioned and to monitor column performance. Peaks were identified by their relative retention time (trimethylacetic acid internal standard) and their mass spectrum. 2-Methylbutanoic acid and 3-methylbutanoic acid coelute but they can be differentiated by their mass spectra and thus by selected ion monito~ng. A &Lafferty rearrangement [15] yields an m/z 60 base peak in the mass spectrum of 3-methy~but~oi~ acid while the same rearrangement yields an m/z 74 base peak for 2-methylbutanoic acid.
Results and discussion
A comprehensive listing of all volatile carboxylic acids detected and identified in plasma or urine samples is presented in Table I . The relative retention time, approximate total ion abundance detection threshold (peak height is twice the noise) and the major fragments observed in the mass spectrum are included for each compound. Because of the injection port temperature (23O*C), it was anticipated that hydroxycarboxylic acids would undergo an acid catalyzed thermal dehydration to the corresponding unsaturated carboxylic acid [16, 17] . However, dehydration did not occur and the hydroxyc~boxyl~c acids were detected unchanged.
The total ion abundance chromatogram of a normal urine and plasma sample is shown in Fig. 2 . Formic acid is a syringe contaminate (see 'Materials and Methods') and is found in every chromatogram.
Lactic acid is a normal plasma ~~~mpotlent ;~nd has been detected in every plasma profile. Volatile neutral i,nd phcnolic cc~mpc~und~ are observed (Fig. 3) Table II. The total ion abundance chromatogram of an abnormal urine sample is shown in Fig. 3 . Lactic acid. tiglic acid (2-methyl-2-buteneoic acid) and 3-keto-2-methylpentanoic acid are not detectable in a normal urine profile. The presence of 3-keto-2-methylpentanoic acid in this urine was postulated to be due to valproic acid therapy. Neither the 3-keto-2-methylpentanoic acid peak nor the tiglic acid peak was present in a urine sample obtained 72 h after removal of the patient from valproic acid. However, the lactic acid peak remained. Tiglic acid may have been produced from the metabolism of 3-keto-2-methylpentanoic acid. The total ion abundance chromatograms of urine samples from a child with vitamin B,,-responsive methylmalonic aciduria are shown in Fig. 4 . The 230°C injection port of the gas chromatograph quantitatively decarboxylates methylmalonic acid to propanoic acid [19, 20] . Upon admission to the hospital (Fig. 4A ) the child's urinary methylmalonic acid excretion was 6.7 mg/mg creatinine (35.0 ~mol/ml).
After 48-h of vitamin B,, therapy, (Fig. 4B ) the urinary methylmalonic acid excretion was 1.0 mg/mg creatinine (5.1 ~mol/ml). Normal urinary methylmalonic acid excretion for a child of the same age ib 30.6 + 14.2 pg/mg creatinine [71.
The volatile carboxylic acids in physiological fluids can be quantified directly from the total ion abundance chromatogram or by the selected ion monitoring of a second injection of the sample. Because of the specificity of the technique. selected ion monitoring affords the best results (Table III) . The base peak in the mass spectrum of each carboxylic acid was the ion monitored. Peak height ratio determination (analyte peak height/internal standard peak height) using the method of standard addition was used to obtain the least squares correlation coefficients shown in Table III .
The day-to-day and the run-to-run peak height variation of a standard volatile carboxylic acid mixture was determined for both total ion abundance and selected ion monitoring (Table IV) . The magnitude of the variability for each procedure shows the need of an internal standard for quantification. The metabolic abnormalities that can be detected by volatile carboxylic acid profiling are characterized by urine and plasma volatile carboxylic acid concentrations that are at least ten times the normal value. The detection limits of this technique (Table I) in urine dictates that any volatile carboxylic acid present in the total ion abundance chromatogram must be present in a greater than normal concentration.
With the exception of lactic acid, the same is true for plasma. A small lactic acid peak (lactic acid peak height/internal standard peak height I 1) is We believe the non-volatile components of plasma and urine are held on the injector side of the SP-1000 column and thus never enter the jet separator or the mass spectrometer.
We routinely change columns and clean the jet separator after 40-50 physiological samples have been profiled. The mass spectrometer 'down time' has not been excessive. In addition, ghost peaks have not been a problem. We routinely inject several microliters of a 1% formic acid solution on to the column after each profile. This reduces ghost peak formation and cleans the jet separator.
The rapid profiling technique described in this report provides for a markedly shortened interval between the time a sample is received and when the diagnostic information is available to the physician. In most inborn errors of carboxylic acid metabolism, a rapid and accurate diagnosis is essential if life-saving measures are to be effective. Precise identification of the defects permits the administration of cofactor therapy or the reduction of toxic dietary nutrients. The sooner these measures are initiated, the better the chance of a good outcome for the patient.
